4.8 Article

Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes

期刊

SCIENCE
卷 352, 期 6284, 页码 459-463

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aad2035

关键词

-

资金

  1. ARC [DE140100432]
  2. National Health and Medical Research Council of Australia (NHMRC) [1083685]
  3. Boehringer Ingelheim
  4. European Research Council from the European Community [291740-LymphoControl]
  5. German Research Foundation
  6. Alexander von Humboldt Foundation
  7. NHMRC [1023454, 1054431, 1020770, 1042582, 637345]
  8. Landsteiner Foundation of Blood Transfusion Research [1136]
  9. ARC
  10. Sylvia and Charles Viertel Foundation
  11. Vidi from The Netherlands Organization of Scientific Research [917.13.338]
  12. Victorian State Government
  13. Australian Government NHMRC Independent Research Institute Infrastructure Support scheme
  14. National Health and Medical Research Council of Australia [1083685] Funding Source: NHMRC

向作者/读者索取更多资源

Tissue-resident memory T (Trm) cells permanently localize to portals of pathogen entry, where they provide immediate protection against reinfection. To enforce tissue retention, Trm cells up-regulate CD69 and down-regulate molecules associated with tissue egress; however, a Trm-specific transcriptional regulator has not been identified. Here, we show that the transcription factor Hobit is specifically up-regulated in Trm cells and, together with related Blimp1, mediates the development of Trm cells in skin, gut, liver, and kidney in mice. The Hobit-Blimp1 transcriptional module is also required for other populations of tissue-resident lymphocytes, including natural killer T (NKT) cells and liver-resident NK cells, all of which share a common transcriptional program. Our results identify Hobit and Blimp1 as central regulators of this universal program that instructs tissue retention in diverse tissue-resident lymphocyte populations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据